Laurent Hennequin

4.2k citations
52 papers · 2.7k indexed · 1 hit paper · h-index 22
Topics
Quinazolinone synthesis and applications (18 papers)PI3K/AKT/mTOR signaling in cancer (10 papers)HER2/EGFR in Cancer Research (10 papers)

In The Last Decade

Laurent Hennequin

52 papers receiving 2.6k citations

Hit Papers

ZD6474 inhibits vascular endothelial growth factor signal...20022026201020182002200400600

Peers

Laurent Hennequin
Comparison fields: 5 of 105
  • Molecular Biology 1.5k
  • Oncology 973
  • Organic Chemistry 773
  • Pulmonary and Respiratory Medicine 500
  • Cancer Research 341
Replace Jon Curwen with:
Jon Curwen United Kingdom
Jennifer L. Stamos United States
Carolyn Discafani United States
Gerhard Siemeister Germany
Jane Kendrew United Kingdom
Richard Kendall United States
Randall Schreck United States
Sally A. Hill United Kingdom
Karen Lackey United States
Giuliana Cassinelli Italy
Laurent Hennequin relative to Jon Curwen United Kingdom Jon Curwen's profile →
Citations per field
00.5×1.6×
Jon Curwen · 1×
Citations per year

Countries citing papers authored by Laurent Hennequin

Since Specialization
Citations

This map shows the geographic impact of Laurent Hennequin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Hennequin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Hennequin more than expected).

Fields of papers citing papers by Laurent Hennequin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Hennequin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Hennequin. The network helps show where Laurent Hennequin may publish in the future.

Co-authorship network of co-authors of Laurent Hennequin

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Hennequin. A scholar is included among the top collaborators of Laurent Hennequin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Hennequin. Laurent Hennequin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 2
5 11
6 3
7 17
8 31
9 72
10 176
11 23
12 29
13 22
14
The discovery of AZD0530: a novel, oral, highly selective and dual-specific inhibitor of the Src and Abl family kinases
16
15 31
16 31
17 23
18
The VEGF receptor tyrosine kinase inhibitor AZD2171 inhibits VEGF signaling, angiogenesis, and tumor growth in vivo
7
19 5
20 34

About Laurent Hennequin

Laurent Hennequin is a scholar working on Organic Chemistry, Oncology and Hematology, having authored 52 papers that have together received 2.7k indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (18 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and HER2/EGFR in Cancer Research (10 papers). The work is most often cited by research in Oncology (973 citations), Organic Chemistry (773 citations) and Cancer Research (341 citations). Laurent Hennequin has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Jon Curwen, Jane Kendrew, Stephen R. Wedge, Patrick A. Plé, Donald Ogilvie, Elaine S. E. Stokes, Andrew P. Thomas, Michael Dukes, Christine Lambert‐van der Brempt and P.F. Wadsworth. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026